Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06133972 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | Clinical Trial |
| Target Enrollment | 550 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | January 26, 2026 (Jan 26, 2026) |
As of March 2, 2026: Clinical trial NCT06133972 is currently recruiting participants. This clinical trial study for systemic lupus erythematosus is actively seeking new participants at 10 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06133972 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06133972 was last updated Jan 26, 2026 (January 26, 2026). HelloStudys verifies this status automatically.